AEROVATE THERAPEUTICS INC (AVTE)

US0080641071 - Common Stock

2.63  +0.03 (+1.15%)

After market: 2.63 0 (0%)

Buy % Consensus

49

ChartMill assigns a Buy % Consensus number of 49% to AVTE. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 2.38. This target is -9.51% below the current price.
AVTE was analyzed by 9 analysts. The buy percentage consensus is at 49. So analysts seem to be rather neutral about AVTE.
In the previous month the buy percentage consensus was at a similar level.
AVTE was analyzed by 9 analysts. More opinions would make the average more meaningful.

Price Target & Forecast

Price Low Median Mean High 2.632.022.042.383.15 - -23.19% -22.43% -9.51% 19.77%
Up and Down Grades
Date Firm Action Rating
2024-06-18 TD Cowen Downgrade Buy -> Hold
2024-06-18 Guggenheim Downgrade Buy -> Neutral
2024-06-18 Wells Fargo Downgrade Overweight -> Equal-Weight
2024-06-18 Evercore ISI Group Downgrade Outperform -> In-Line
2024-06-17 BTIG Downgrade Buy -> Neutral
2024-06-17 Jefferies Downgrade Buy -> Hold
2024-06-06 Wedbush Reiterate Outperform -> Outperform
2024-05-22 Wedbush Reiterate Outperform -> Outperform
2024-05-14 Wedbush Reiterate Outperform -> Outperform
2024-04-01 Wells Fargo Maintains Overweight -> Overweight
2023-03-01 Guggenheim Initiate Buy
2022-12-06 BTIG Upgrade Neutral -> Buy
2022-08-16 BTIG Downgrade Buy -> Neutral
2022-02-11 BTIG Initiate Buy
2021-07-26 Cowen & Co. Initiate Outperform
2021-07-26 Wedbush Initiate Outperform
2021-07-26 Evercore ISI Group Initiate Outperform
2021-07-26 Jefferies Initiate Buy